Headline News about Johnson & Johnson
Johnson & Johnson Unusual Options Activity
September 12, 2023
Via Benzinga
Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations
September 14, 2023
Via Benzinga
Topics
Lawsuit
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via Benzinga
Analyst Ratings for Johnson & Johnson
September 08, 2023
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
Via Benzinga
Exposures
Product Safety
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|